What question did this study set out to answer?

This review aims to summarize published studies assessing the cost effectiveness of screening for Chlamydia trachomatis.

Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies

View Full Paper

Ask AI

Bookmark

Authors

Review evaluates screening cost effectiveness for Chlamydia trachomatis, suggesting necessary improvements for accurate data validation.

This review aims to summarize published studies assessing the cost effectiveness of screening for Chlamydia trachomatis.
Literature search conducted on Medline and Health Star from 1990-2000.
Assessment of articles was made based on the Drummond criteria for economic evaluations.
Focus was on asymptomatic sexually active women under 30 in primary care settings.
All 10 reviewed studies found screening to be more cost effective than testing symptomatic women based on modeled scenarios.
Screening was cost effective at C trachomatis prevalence rates of 3.1-10.0% and cost saving at 1.1% with age selection and urine DNA tests.
The models relied on assumptions that need further data confirmation regarding complications of asymptomatic lower tract infections.

Emma Honey (2002) studied this question.

View Full Paper

Ask AI

Bookmark